A controlled comparison of oxypertine and perphenazine in schizophrenic psychoses.
D000293:Adolescent; D000328:Adult; D001714:Bipolar Disorder / Q000188:drug therapy; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007211:Indoles / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009069:Movement Disorders / Q000139:chemically induced; D010546:Perphenazine / Q000009:adverse effects / Q000627:therapeutic use*; D010879:Piperazines / Q000009:adverse effects / Q000627:therapeutic use*; D012559:Schizophrenia / Q000188:drug therapy*; D014149:Tranquilizing Agents / Q000009:adverse effects / Q000627:therapeutic use*
D007211:Indoles; D010879:Piperazines; D014149:Tranquilizing Agents; D010546:Perphenazine